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Abstract  
Complexity of post-genomic data and multiplicity of mining strategies are two limits to Knowledge 
Discovery in Databases (KDD) in life sciences. Because they provide a semantic frame to data and 
because they benefit from the progress of semantic web technologies, bio-ontologies should be 
considered for playing a key role in the KDD process. In the frame of a case study relative to the 
search of genotype-phenotype relationships, we demonstrate the capability of bio-ontologies to guide 
data selection during the preparation step of the KDD process.  We propose three scenarios to 
illustrate how domain knowledge can be taken into account in order to select or aggregate data to 
mine, and consequently how it can facilitate result interpretation at the end of the process. 
1 Background  
One of the promising interests of bio-ontologies is their use for guiding the process of 
Knowledge Discovery in Databases (KDD). The KDD process has been successfully used in 
various domains such as finance or biomedicine [8]. However application cases are limited by 
the fact that it still necessitates a close interaction between the system and domain experts. 
Because the data manipulated in life sciences are complex, and because data mining 
algorithms generate large amounts of raw results, the interpretation step of KDD in biology is 
particularly tricky and discouragingly time-consuming.  
Existing bio-ontologies help in giving structure to the amounts of complex data in life 
sciences. The National Center for Biomedical Ontology (NCBO) has recently developed the 
Bioportal [3] that provides a unified panorama of bio-ontologies from a unique web site [12]. 
In computer science, ontologies formalise a shared understanding of knowledge about a 
particular domain [9]. 
All along the KDD process, domain knowledge, embedded within ontologies, can be used for 
guiding the various steps [2]: 
(1) During the data preparation step, it facilitates integration of heterogeneous data, and 
guides the selection of relevant data to mine, 
(2) During the mining step, domain knowledge allows specifying constraints for mining 
algorithms,  
(3) In the interpretation step, it helps experts for validating the extracted knowledge units 
before integrating them. 
We distinguish here the data mining, which is limited to the execution of a mining algorithm, 
from the whole KDD process that includes data preparation and result interpretation. 
In a previous work we stressed on the role of ontologies in data integration [5]. In this paper 
we focus on the selection of data that deserve mining. This step is usually performed by 
experts who use their own knowledge for selecting the most relevant  data. We explore here 
how the availability of an ontology and its associated Knowledge Base (KB) can assist the 
expert in his task.  
Filling the gap between genotype and phenotype is of principal interest in biology research. 
Large scale clinical studies enable the recording of many genomic and post-genomic data 
 
thanks to new biotechnology tools (microarray, mass spectrometry, etc.). Recent studies 
[4,11] show that data mining methods are promising approaches for the exploration of 
correlations between genotype and phenotype data inside the large amounts of data that result 
from this kind of studies. However it also illustrates that such analyses are particularly 
delicate to manage because of the two difficulties mentioned previously: domain complexity 
and amount of data. 
Section 2 presents a case study, with a dataset, an ontology and a KB that will be used for the 
data selection. Section 3 proposes three different scenarios that make use of the ontology in 
order to guide data selection. Section 4 discusses the obtained results and concludes on this 
work. 
2 A Case Study 
Searching for Variant-Phenotype Trait Relationships 
We illustrate the benefit of using an ontology for the data selection problem in KDD with a 
real biological problem and a real dataset relative to Familial Hypercholesterolemia (FH). 
KDD process is used here to reveal relationships between genomic variants and phenotype 
traits. Such relationships could then be used to identify modulator variants, i.e. any variant (or 
any group of variants) related to a modulation in the disease or in a disease symptom. For 
instance, depending on allele versions of two genomic variants of the APOE gene (rs7418 and 
rs429358) various levels of severity are observed in the FH. Modulator variants are 
particularly interesting in pharmacogenomics since they are known to modulate the activity of 
drug pathways, and consequently to modulate the drug effect.  
The FH Dataset  
Our dataset concerns:  
(α)  patients affected by the genetic hypercholesterolemia (FH),   
(β) patients affected by a non-genetic hypercholesterolemia, and  
(γ)  patients without any hypercholesterolemia.  
Genotype attributes describe observed alleles for genomic variants of the LDLR gene.  An 
example of genotype attribute is the observed allele for the variant located at position 
Chr19:11085058 (e.g. AA). Phenotype attributes describe traits usually observed when 
studying the metabolism of lipids. Two examples of phenotype attributes are the LDL blood 
concentration (e.g. [LDL]b= 3 g.l
-1
) and the presence of xanthoma. Table 1 describes 
quantitatively the FH dataset. 
Table 1: Characteristics of the FH dataset 
 Nature Number Total number 






Preliminary Data Mining 
A preliminary exploration consisted in submitting the whole FH dataset to two different 
unsupervised data mining algorithms. The first one is association rule search with the Apriori 
algorithm [1], the second one is a clustering with the COBWEB algorithm [7]. Apriori and 
COBWEB implementations used for all the reported mining tasks are those of the Weka 
toolbox [15]. 
 
With Apriori (support=99%, confidence=0.9), the total number of itemsets for the generation 
of rules is 223, with 169 itemsets strictly larger than 2.  
With COBWEB (acuity=1, cutoff=0.5), the total number of clusters is 187 (Table 2, 1st 
column).  
These preliminary results revealed complex to interpret  due to the large amount of variants 
involved and the lack of contextual data. For instance, variants (which are identified by a 
simple label) located in coding sequence are difficult to distinguish from those located in non 
coding sequence, similarly normal values of LDL blood concentration are difficult to 
distinguish from pathologic ones. In addition the existence of haplotypes generates noise in 
the form of trivial associations. 
SNP-Ontology and SNP-Knowledge Base about the Genomic Variations of the LDLR 
gene  
The SNP-Ontology [13] embeds a formal description in OWL-DL of genomic variations and 
their related concepts: sequence in which they are observed, haplotype they belong to, 
proteins they modify, database in which they are stored, etc.. We populate for our case-study 
a SNP-Knowledge Base that follows the semantic structure of the SNP-Ontology and 
integrates knowledge about genomic variations of the LDLR gene. The method used to 
populate the SNP-KB is precisely described in [5]. We illustrate with the SNP-Ontology and 
the SNP-KB three different kinds of semantic operators that we use for guiding data selection 















Figure 1             
The SNP-Ontology and the SNP-KB. Some classes of the SNP-Ontology and instances of the SNP-
KB. Plain arrows represent subsumptions, dotted arrows represent instantiations,  bold arrows 
represent object properties. 
3 Guiding Data Selection with Domain Knowledge 
Attribute Selection thanks to Subsumption 
The hierarchical structure of the ontology enables browsing top-down or bottom-up for a 
progressive selection of attribute. For instance the FH dataset can be progressively focused on 
more and more specific classes of variants. Table 2 shows the reduction of results on a data 
mining dealing first with all variants (variant), then focusing on variants from coding regions 
(coding_variant), and finally on variants that induce a modification in conserved domain of 
proteins (conserved_domain_variant). Conversely, the way back permits to enlarge the 
my_rs_688 := isHaplotypeMemberOf(haplotype_NA06993) 
my_rs_688 := isHaplotypeMemberOf(isTaggedBy(my_rs_5930)) 
 
number of mined variants and to generalize associations that may have been revealed on 
smaller attribute sets.  
Table 2: Quantitative characterization of the complexity of data mining results depending on attribute 
selection 
 variant coding_variant conserved_domain_variant tag_snp 
  Variants to Mine 289 231 150 176 
  Resulting Itemsets (L>2) 169 169 49 32 
  Resulting Clusters 187 178 82 46 
 
Attribute Aggregation thanks to Object Properties 
Because relationships between instances in KB bring information about dependencies 
between corresponding attributes, they could serve to aggregate these attributes. Haplotypes 
illustrate appropriately this aggregation process. In simple words, a group of variants that 
segregate uniformly (the haplotype) could be replaced by a single variant (the tag-SNP). Since 
the SNP-KB does integrate haplotype information from the HapMap project [10], it enables to 
identify tag-SNPs and haplotype members (Figure 1). Thus attribute selection can be limited 
to tag-SNPs (tag_snp) which considerably reduces the number of attributes (Table 2). The 
amount of results to interpret is therefore reduced not only because of decreasing attribute 
number but also because of reducing dependencies between selected attributes.  
More generally, aggregation can be envisaged between attributes as soon as functional 
dependency exists between them (e.g. date of birth determines age). In the previous example, 
the haplotype definition is interpreted as a functional dependency between occurrences of tag-
SNP and haplotype members. However, this interpretation is subordinated to the precision of 
haplotype construction and thus deserves attention.  
Object Selection thanks to Class Description 
In contrast with the two previous scenarios dedicated to attribute (e.g. variant) selection, this 
subsection illustrates the object (patient) selection that reduces amount of data as well. 
Furthermore, this third scenario illustrates more particularly the selection of instances that 
correspond to a defined class description (including constraints in addition to subsumption 
and object properties). 
In our FH case study we define groups of patients which are suspected to present specific 
genotype-phenotype profiles. For this purpose, we use the SO-Pharm ontology [14] which 
embeds knowledge about clinical studies in pharmacogenomics [6]. A SO-Pharm-KB has 
been populated with private data from the FH dataset according to the method mentioned in 
the last subsection of the section 2. 
Classes and properties of SO-Pharm enable us to describe four classes of patients: one that 
already exists in SO-Pharm, and three others that have been specially defined. 
  
  patient     (defined in SO-Pharm)  
  patient_α := patient П  presentsGenotypeItem (hasValue (LDLR_mutation))  
  patient_β := patient П  presentsGenotypeItem (hasValue (no_LDLR_mutation) ) 
                       П  presentsPhenotypeItem (hasValue (hight_LDL_in_blood))  
  patient_γ := patient П  presentsGenotypeItem (hasValue (no_LDLR_mutation) ) 
                                     П presentsPhenotypeItem (hasValue(normal_LDL_in_blood)) 
 
 
Selecting instances from only one class enables to reduce the amount of data, and to mine the 
resulting subset in order to characterize it. This mining task may benefit from prior attribute 
selection and aggregation as detailed in previous scenarios. 
4 Discussion and Conclusion 
This paper demonstrates in the frame of a case study how domain knowledge captured in bio-
ontologies and KB facilitates the KDD process. Proposed scenarios can be combined so as to 
define a KDD strategy in accordance with biomedical objectives. Additional scenarios can 
also be envisaged such as object aggregation. In our case study, object aggregation could 
consist in grouping together patients from the same family thereby retaining a unique 
representing member for each family. 
The aggregation process is based on relationships between instances and is consequently 
dependent on data quality. If an instance is missing or is wrong, the aggregation will be 
impossible or wrong. However, knowledge about haplotypes could also serve for completing 
missing values about observed alleles of each haplotype member.  
The next step of our work will deal with implementing a framework for guiding the data 
preparation in accordance with defined scenarios. This requires a knowledge base system that 
enables ontology edition, management of large OWL dataset, and instance retrieval, in order 
to ensure seamless junction between domain knowledge and data. 
Challenging future works may focus on how to automatically formalize results of the KDD 
process in order to enrich both the ontology and the KB. Such a capability would enable to 
iteratively run the KDD process, using an enriched domain knowledge at each iteration.  
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